News & Events
In the news
The quarterly scientific journal
Clean Mails
Here is the last edition of our quarterly Clean Mails newsletter, having as main subject: "BSL3 GMP manufacturing suite". To read about this and find out Clean Cells, Naobios and Biodextris’ news or to receive our next editions, click here.
Upstream process optimization of bacteriophage production
using Design of Experiment
Clean Cells’ process development department has worked on implementing a robust and flexible Design of Experiment approach for upstream process optimization leading to higher titers and the characterization of a design space.
Congress
Meet our teams at CPHI Worldwide
Meet the teams from companies Clean Cells & Naobios next November as they attend CPHI Worldwide.
New Webinar
Veterinary framework: from regulation to GMP characterization of biologics
The theme of this new webinar will be « Veterinary framework : from regulation to GMP characterization of biologics » and will take place on 7th October 2021.
The quarterly scientific journal
Clean Mails
Here is the fourth edition of our quarterly Clean Mails newsletter, having as main subject: "Implementing digital PCR : a quality leap for the quantification of nucleic acids". To read about this and find out Clean Cells, Naobios and Biodextris’ news or to receive our next editions, click here.
Patent for potency assay evaluating cytolytic activity
Potency evaluation of cytolytic activity: cutting-edge innovation for your product
Our assay development team at Clean Cells continuously works on innovative methods for the potency evaluation of biologics. Today, the patent for the method used to assess cytolytic activity in biologics is extended to Canada, thus illustrating the growth of Clean Cells and its inherent assay development expertise.
Press Release
Clean Cells invests over €13M in new biopharmaceutical production site
5,300 m2 new facility will quadruple analysis and production capacity, becoming largest site in Europe for biopharmaceuticals quality control services and production of cell banks for innovative drugs.
Webinar – Cell based therapeutic product: cytogenetic challenges and solutions
Is your cell product free from genetic abnormalities?
Our next webinar will touch on genetic safety using Karyology and FISH analysis in compliance with regulation regarding cells based products for multiple applications such as gene modified cell therapy. It will gather our cytogenetic expert, the Dr. Vasileios N. Georgakakos joined by our business developer Aymeric Huguenot, on the 17th of June at 4PM.